                         SEQUENCE LISTING

<110>  Angiochem Inc.
 
<120>  METHODS FOR THE TREATMENT OF LEPTOMENINGEAL CARCINOMATOSIS

<130>  50546-072WO3

<150>  PCT/US16/37626
<151>  2016-06-15

<150>  US 62/257,562
<151>  2015-11-19

<150>  US 62/175,948
<151>  2015-06-15

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETIC CONSTRUCT

<400>  1

Thr Phe Phe Tyr Gly Gly Cys Arg Gly Lys Arg Asn Asn Phe Lys Thr 
1               5                   10                  15      


Glu Glu Tyr 
            


<210>  2
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETIC CONSTRUCT

<400>  2

Thr Phe Phe Tyr Gly Gly Ser Arg Gly Lys Arg Asn Asn Phe Lys Thr 
1               5                   10                  15      


Glu Glu Tyr 
            


<210>  3
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETIC CONSTRUCT


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is D-Arginine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is D-Lysine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is D-Arginine

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is D-Lysine

<400>  3

Thr Phe Phe Tyr Gly Gly Ser Xaa Gly Xaa Xaa Asn Asn Phe Xaa Thr 
1               5                   10                  15      


Glu Glu Tyr 
            


